SCHEMBL4164253

SCHEMBL4164253

Clc1ccccc1NN=C(Br)Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.47
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
HPGD P15428 3/20 0.47
HTT P42858 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
LMNA P02545 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
GAA P10253 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
POLB P06746 1/20 0.43
APEX1 P27695 1/20 0.43
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6068420 0.80 MEN1 (0.52) MAPTMEN1KMT2AHPGDHTT
SCHEMBL6068417 0.80 MEN1 (0.52) MAPTMEN1KMT2AHPGDHTT
2-Chlorocarbonylcyanide Phenylhydrazine SCHEMBL922278 0.75 MAPT (0.59) MAPTMEN1KMT2AHPGDHTT
SCHEMBL3839304 0.73 MAPT (0.54) MAPTMEN1KMT2AHPGDHTT
SCHEMBL518603 0.73 MAPT (0.50) MAPTMEN1KMT2AHPGDHTT
SCHEMBL3839303 0.73 MAPT (0.54) MAPTMEN1KMT2AHPGDHTT
SCHEMBL13817618 0.73 GAA (0.44) MAPTMEN1KMT2AHPGDLMNA
SCHEMBL9067491 0.72 MAPT (0.49) MAPTMEN1KMT2AHPGDHTT
SCHEMBL9067490 0.72 MAPT (0.49) MAPTMEN1KMT2AHPGDHTT
SCHEMBL1096366 0.71 MAPT (0.48) MAPTMEN1KMT2AHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2564706-A1 Anthranilamide insecticides E. I. du Pont de Nemours and Company (US) 2013-03-06 EP disclosed
US-20090133318-A1 Anthranilamide insecticides E. I. DU PONT DE NEMOURS AND COMPANY 2009-05-28 US disclosed
US-20070184018-A1 Anthranilamide insecticides E. I. DU PONT DE NEMOURS AND COMPANY 2007-08-09 US disclosed
EP-1812421-A2 ANTHRANILAMIDE INSECTICIDES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2007-08-01 EP disclosed
EP-1751112-A2 ANTHRANILAMIDE INSECTICIDES E.I.Du pont de nemours and company (US) 2007-02-14 EP disclosed
WO-2006055922-A2 ANTHRANILAMIDE INSECTICIDES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-05-26 WO disclosed
WO-2005118552-A2 ANTHRANILAMIDE INSECTICIDES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090133318-A1 Anthranilamide insecticides C3AR1, C5, C1S MAPT 4867/4885MEN1 2396/4885KMT2A 478/4885
US-20070184018-A1 Anthranilamide insecticides F12, CBR3, F3 MAPT 4791/4885MEN1 1157/4885KMT2A 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.